Clinical Trials Directory

Trials / Conditions / Hypophosphatasia (HPP)

Hypophosphatasia (HPP)

9 registered clinical trials studyying Hypophosphatasia (HPP) — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Ad
NCT07179640
Alesta TherapeuticsPhase 1 / Phase 2
UnknownEvaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP)
NCT04181164
Hvidovre University Hospital—
Enrolling By InvitationRegistry of Patients With Hypophosphatasia
NCT02306720
Alexion Pharmaceuticals, Inc.—
CompletedRetrospective, Non-interventional Natural History of Patients With Juvenile-onset Hypophosphatasia (HPP)
NCT02104219
Alexion Pharmaceuticals, Inc.—
CompletedA Retrospective Study of the Natural History of Patients With Severe Perinatal and Infantile Hypophosphatasia
NCT01419028
Alexion Pharmaceuticals, Inc.—
CompletedExtension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP)
NCT01203826
Alexion Pharmaceuticals, Inc.Phase 2
CompletedSafety and Efficacy of Asfotase Alfa in Juvenile Patients With Hypophosphatasia (HPP)
NCT00952484
Alexion Pharmaceuticals, Inc.Phase 2
CompletedSafety and Efficacy Study of Asfotase Alfa in Severely Affected Infants With Hypophosphatasia (HPP)
NCT00744042
Alexion Pharmaceuticals, Inc.Phase 1 / Phase 2
CompletedSafety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adu
NCT00739505
Alexion Pharmaceuticals, Inc.Phase 1